Trinity Biotech plc (TRIB)
USD 0.85
(6.99%)
USD 0.85
(6.99%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 59.43 Million USD | -35.47% |
| 2022 | 92.1 Million USD | -22.53% |
| 2021 | 118.89 Million USD | -8.82% |
| 2020 | 130.39 Million USD | -0.51% |
| 2019 | 131.07 Million USD | -13.33% |
| 2018 | 151.23 Million USD | -21.48% |
| 2017 | 192.61 Million USD | -22.83% |
| 2016 | 249.59 Million USD | -30.47% |
| 2015 | 358.95 Million USD | 47.82% |
| 2014 | 242.84 Million USD | 7.22% |
| 2013 | 226.48 Million USD | 14.73% |
| 2012 | 197.4 Million USD | 15.11% |
| 2011 | 171.49 Million USD | 6.6% |
| 2010 | 160.87 Million USD | 21.46% |
| 2009 | 132.44 Million USD | 2.27% |
| 2008 | 129.5 Million USD | -40.04% |
| 2007 | 215.97 Million USD | -13.31% |
| 2006 | 249.13 Million USD | 34.96% |
| 2005 | 184.6 Million USD | 22.39% |
| 2004 | 150.82 Million USD | 27.72% |
| 2003 | 118.09 Million USD | 32.29% |
| 2002 | 89.26 Million USD | 15.89% |
| 2001 | 77.02 Million USD | 14.57% |
| 2000 | 67.23 Million USD | 49.26% |
| 1999 | 45.04 Million USD | 0.09% |
| 1998 | 45 Million USD | 82.93% |
| 1997 | 24.6 Million USD | 83.58% |
| 1996 | 13.4 Million USD | 45.65% |
| 1995 | 9.2 Million USD | 196.77% |
| 1994 | 3.1 Million USD | -36.73% |
| 1993 | 4.9 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 94.35 Million USD | 4.48% |
| 2024 Q1 | 90.3 Million USD | 51.94% |
| 2023 Q1 | 91.15 Million USD | -1.03% |
| 2023 FY | 59.43 Million USD | -35.47% |
| 2023 Q4 | 59.43 Million USD | -6.54% |
| 2023 Q3 | 63.59 Million USD | -11.66% |
| 2023 Q2 | 71.99 Million USD | -21.03% |
| 2022 Q3 | 97.89 Million USD | -8.63% |
| 2022 Q2 | 107.14 Million USD | 0.98% |
| 2022 Q4 | 92.1 Million USD | -5.92% |
| 2022 FY | 92.1 Million USD | -22.53% |
| 2022 Q1 | 106.09 Million USD | -10.76% |
| 2021 Q1 | 135.97 Million USD | 4.28% |
| 2021 Q3 | 122.77 Million USD | -1.56% |
| 2021 Q4 | 118.89 Million USD | -3.16% |
| 2021 FY | 118.89 Million USD | -8.82% |
| 2021 Q2 | 124.72 Million USD | -8.28% |
| 2020 Q3 | 136.07 Million USD | 5.71% |
| 2020 Q1 | 129.12 Million USD | -1.48% |
| 2020 FY | 130.39 Million USD | -0.51% |
| 2020 Q2 | 128.72 Million USD | -0.31% |
| 2020 Q4 | 130.39 Million USD | -4.17% |
| 2019 FY | 131.07 Million USD | -13.33% |
| 2019 Q4 | 131.07 Million USD | -24.35% |
| 2019 Q3 | 173.25 Million USD | 0.9% |
| 2019 Q2 | 171.7 Million USD | -0.55% |
| 2019 Q1 | 172.64 Million USD | 14.16% |
| 2018 Q1 | 194.68 Million USD | 1.07% |
| 2018 Q2 | 194.44 Million USD | -0.12% |
| 2018 Q3 | 183.32 Million USD | -5.72% |
| 2018 Q4 | 151.23 Million USD | -17.51% |
| 2018 FY | 151.23 Million USD | -21.48% |
| 2017 Q1 | 245.13 Million USD | -1.78% |
| 2017 Q4 | 192.61 Million USD | -21.26% |
| 2017 Q2 | 244.79 Million USD | -0.14% |
| 2017 Q3 | 244.62 Million USD | -0.07% |
| 2017 FY | 192.61 Million USD | -22.83% |
| 2016 Q4 | 249.59 Million USD | -30.76% |
| 2016 Q1 | 360.03 Million USD | 0.3% |
| 2016 Q2 | 357.77 Million USD | -0.63% |
| 2016 Q3 | 360.46 Million USD | 0.75% |
| 2016 FY | 249.59 Million USD | -30.47% |
| 2015 Q1 | 246.77 Million USD | 1.62% |
| 2015 Q4 | 358.95 Million USD | 1.01% |
| 2015 FY | 358.95 Million USD | 47.82% |
| 2015 Q3 | 355.37 Million USD | -1.22% |
| 2015 Q2 | 359.76 Million USD | 45.79% |
| 2014 Q3 | 236.99 Million USD | -0.61% |
| 2014 Q1 | 228.91 Million USD | 1.07% |
| 2014 FY | 242.84 Million USD | 7.22% |
| 2014 Q2 | 238.44 Million USD | 4.16% |
| 2014 Q4 | 242.84 Million USD | 2.47% |
| 2013 Q1 | 203.38 Million USD | 3.03% |
| 2013 Q2 | 203.44 Million USD | 0.03% |
| 2013 FY | 226.48 Million USD | 14.73% |
| 2013 Q3 | 222.88 Million USD | 9.55% |
| 2013 Q4 | 226.48 Million USD | 1.62% |
| 2012 Q3 | 189.9 Million USD | 3.24% |
| 2012 Q4 | 197.4 Million USD | 3.95% |
| 2012 Q1 | 181.96 Million USD | 6.1% |
| 2012 Q2 | 183.95 Million USD | 1.09% |
| 2012 FY | 197.4 Million USD | 15.11% |
| 2011 Q2 | 168.02 Million USD | 1.45% |
| 2011 Q1 | 165.63 Million USD | 2.96% |
| 2011 Q4 | 171.49 Million USD | 1.17% |
| 2011 Q3 | 169.51 Million USD | 0.88% |
| 2011 FY | 171.49 Million USD | 6.6% |
| 2010 Q2 | 153.25 Million USD | 15.87% |
| 2010 Q1 | 132.26 Million USD | -0.14% |
| 2010 FY | 160.87 Million USD | 21.46% |
| 2010 Q4 | 160.87 Million USD | 1.83% |
| 2010 Q3 | 157.98 Million USD | 3.08% |
| 2009 Q4 | 132.44 Million USD | 1.61% |
| 2009 Q3 | 130.34 Million USD | -0.66% |
| 2009 FY | 132.44 Million USD | 2.27% |
| 2009 Q2 | 131.21 Million USD | 5.19% |
| 2009 Q1 | 124.73 Million USD | -3.68% |
| 2008 FY | 129.5 Million USD | -40.04% |
| 2008 Q3 | 215.65 Million USD | -0.52% |
| 2008 Q4 | 129.5 Million USD | -39.95% |
| 2008 Q2 | 216.77 Million USD | 1.78% |
| 2008 Q1 | 212.98 Million USD | -1.39% |
| 2007 Q4 | 215.97 Million USD | 0.0% |
| 2007 Q2 | 248.36 Million USD | 0.01% |
| 2007 FY | 215.97 Million USD | -13.31% |
| 2007 Q1 | 248.34 Million USD | -0.32% |
| 2006 Q1 | 178.6 Million USD | -3.25% |
| 2006 FY | 249.13 Million USD | 34.96% |
| 2006 Q4 | 249.13 Million USD | 1.42% |
| 2006 Q3 | 245.64 Million USD | 1.95% |
| 2006 Q2 | 240.95 Million USD | 34.91% |
| 2005 FY | 184.6 Million USD | 22.39% |
| 2005 Q2 | 160.77 Million USD | 2.3% |
| 2005 Q1 | 157.16 Million USD | 4.2% |
| 2005 Q4 | 184.6 Million USD | 3.46% |
| 2005 Q3 | 178.42 Million USD | 10.98% |
| 2004 FY | 150.82 Million USD | 27.72% |
| 2004 Q4 | 150.82 Million USD | -1.81% |
| 2004 Q3 | 153.61 Million USD | 0.23% |
| 2004 Q2 | 153.26 Million USD | 4.98% |
| 2004 Q1 | 145.99 Million USD | 23.62% |
| 2003 Q1 | 91.89 Million USD | 2.94% |
| 2003 Q2 | 90.93 Million USD | -1.04% |
| 2003 FY | 118.09 Million USD | 32.29% |
| 2003 Q3 | 112.42 Million USD | 23.63% |
| 2003 Q4 | 118.09 Million USD | 5.04% |
| 2002 Q3 | 80.65 Million USD | 3.56% |
| 2002 Q2 | 77.88 Million USD | -0.6% |
| 2002 Q4 | 89.26 Million USD | 10.68% |
| 2002 Q1 | 78.35 Million USD | 1.72% |
| 2002 FY | 89.26 Million USD | 15.89% |
| 2001 Q2 | 71.14 Million USD | 5.19% |
| 2001 Q1 | 67.62 Million USD | 0.59% |
| 2001 Q4 | 77.02 Million USD | 8.51% |
| 2001 FY | 77.02 Million USD | 14.57% |
| 2001 Q3 | 70.98 Million USD | -0.22% |
| 2000 Q1 | 51.26 Million USD | 13.81% |
| 2000 FY | 67.23 Million USD | 49.26% |
| 2000 Q4 | 67.23 Million USD | 12.43% |
| 2000 Q2 | 57.92 Million USD | 12.99% |
| 2000 Q3 | 59.79 Million USD | 3.24% |
| 1999 Q4 | 45.04 Million USD | -1.65% |
| 1999 Q3 | 45.8 Million USD | -2.76% |
| 1999 Q2 | 47.1 Million USD | 8.03% |
| 1999 Q1 | 43.6 Million USD | -3.11% |
| 1999 FY | 45.04 Million USD | 0.09% |
| 1998 Q3 | 44.1 Million USD | 63.33% |
| 1998 Q4 | 45 Million USD | 2.04% |
| 1998 Q2 | 27 Million USD | 0.0% |
| 1998 FY | 45 Million USD | 82.93% |
| 1997 FY | 24.6 Million USD | 83.58% |
| 1997 Q4 | 24.6 Million USD | 0.0% |
| 1996 Q4 | 13.4 Million USD | 0.0% |
| 1996 FY | 13.4 Million USD | 45.65% |
| 1995 Q4 | 9.2 Million USD | 0.0% |
| 1995 FY | 9.2 Million USD | 196.77% |
| 1994 FY | 3.1 Million USD | -36.73% |
| 1994 Q1 | 4.9 Million USD | 0.0% |
| 1993 FY | 4.9 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | 69.892% |
| Biodesix, Inc. | 99.09 Million USD | 40.023% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -622.917% |
| Castle Biosciences, Inc. | 477.81 Million USD | 87.561% |
| DarioHealth Corp. | 96.38 Million USD | 38.338% |
| Exact Sciences Corporation | 6.47 Billion USD | 99.082% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 98.177% |
| Illumina, Inc. | 10.11 Billion USD | 99.412% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -331.349% |
| iSpecimen Inc. | 15.81 Million USD | -275.716% |
| Standard BioTools Inc. | 323.06 Million USD | 81.603% |
| 23andMe Holding Co. | 395.16 Million USD | 84.96% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 96.413% |
| NeoGenomics, Inc. | 1.68 Billion USD | 96.465% |
| Inotiv, Inc. | 856.53 Million USD | 93.061% |
| Psychemedics Corporation | 13.27 Million USD | -347.89% |
| Prenetics Global Limited | 254.17 Million USD | 76.616% |
| Precipio, Inc. | 18.1 Million USD | -228.352% |
| RadNet, Inc. | 2.88 Billion USD | 97.941% |
| Sotera Health Company | 3.13 Billion USD | 98.101% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 31.663% |
| Exagen Inc. | 56.94 Million USD | -4.374% |
| Natera, Inc. | 1.45 Billion USD | 95.921% |
| Aspira Women's Health Inc. | 6.26 Million USD | -849.138% |
| Neogen Corporation | 4.58 Billion USD | 98.703% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 95.042% |
| ICON Public Limited Company | 16.98 Billion USD | 99.65% |
| Bionano Genomics, Inc. | 214.4 Million USD | 72.279% |
| CareDx, Inc | 484.61 Million USD | 87.736% |
| Check-Cap Ltd. | 25.01 Million USD | -137.578% |
| Twist Bioscience Corporation | 776.4 Million USD | 92.345% |
| Guardant Health, Inc. | 1.78 Billion USD | 96.673% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -421.369% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 95.332% |
| Sera Prognostics, Inc. | 95.44 Million USD | 37.726% |
| OPKO Health, Inc. | 2.01 Billion USD | 97.046% |
| Personalis, Inc. | 225.09 Million USD | 73.596% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -335.371% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 31.663% |
| MDxHealth SA | 129.13 Million USD | 53.973% |
| Prenetics Global Limited | 254.17 Million USD | 76.616% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -779.978% |
| Mainz Biomed B.V. | 15.4 Million USD | -285.715% |
| Neuronetics, Inc. | 115.83 Million USD | 48.688% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -622.917% |